Therapeutic cannabinoids in multiple sclerosis: immunomodulation revisited
- PMID: 29633480
- DOI: 10.1111/ene.13658
Therapeutic cannabinoids in multiple sclerosis: immunomodulation revisited
Comment on
-
Clinical response to Nabiximols correlates with the downregulation of immune pathways in multiple sclerosis.Eur J Neurol. 2018 Jul;25(7):934-e70. doi: 10.1111/ene.13623. Epub 2018 Apr 16. Eur J Neurol. 2018. PMID: 29528549
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
